Quality By Design: Better Data Using Participant Insights

Quality assurance is not merely a supplementary component of clinical trials; it is an essential and foundational element that is considered from the onset of protocol development. Despite the inevitable obstacles that arise in ensuring high-quality experiences and data collection in clinical research, there is a methodology that has garnered support from regulatory bodies and demonstrated efficacy in achieving superior results.

This method is known as the “quality by design” approach, which emphasizes the importance of incorporating input from all relevant parties, especially those directly impacted by the trial's protocols, such as participants and sites.

In this whitepaper, you will discover the significance of adopting a participant-centered, quality-by-design framework for enhancing the integrity and quality of clinical trial data.